EOM Pharmaceuticals Holdings Management
Management criteria checks 1/4
EOM Pharmaceuticals Holdings' CEO is Irach Taraporewala, appointed in Dec 2021, has a tenure of 2.33 years. directly owns 2.39% of the company’s shares, worth $536.05K. The average tenure of the management team and the board of directors is 2.3 years and 2 years respectively.
Key information
Irach Taraporewala
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | 2.4% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$5m |
| Mar 31 2022 | n/a | n/a | -US$5m |
| Dec 31 2021 | US$266k | US$21k | -US$5m |
Compensation vs Market: Insufficient data to establish whether Irach's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Irach's compensation with company performance.
CEO
Irach Taraporewala (67 yo)
2.3yrs
Tenure
US$265,646
Compensation
Dr. Irach B. Taraporewala, BS, M.S., PhD, serves as Chief Executive Officer and Director at ImmunoCellular Therapeutics, Ltd since December 1, 2021 also its President. He had been Chief Executive Officer o...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$265.65k | 2.39% $ 536.0k | |
| CFO & Treasurer | 2.3yrs | US$150.00k | 0.74% $ 166.0k | |
| Founder | 2.3yrs | no data | 87.05% $ 19.5m | |
| Co-Founder | 2.3yrs | no data | 4.78% $ 1.1m |
2.3yrs
Average Tenure
68yo
Average Age
Experienced Management: IMUC's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$265.65k | 2.39% $ 536.0k | |
| Founder | 2.3yrs | no data | 87.05% $ 19.5m | |
| Independent Director | 2yrs | no data | no data | |
| Independent Director | 2yrs | no data | no data | |
| Independent Director | 2yrs | no data | no data |
2.0yrs
Average Tenure
61yo
Average Age
Experienced Board: IMUC's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.